
### [NCIT:C5495](http://purl.obolibrary.org/obo/NCIT_C5495)
**Label:** Colon Sarcoma

**Subclasses:** [NCIT:C5516](http://purl.obolibrary.org/obo/NCIT_C5516) (Colon Kaposi Sarcoma), [NCIT:C5494](http://purl.obolibrary.org/obo/NCIT_C5494) (Colon Leiomyosarcoma), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38829](http://purl.obolibrary.org/obo/NCIT_C38829) (Focal Adhesion Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38828](http://purl.obolibrary.org/obo/NCIT_C38828) (Inositol Phosphate Metabolism Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3880](http://purl.obolibrary.org/obo/NCIT_C3880) (Eyelid Nevus))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38784](http://purl.obolibrary.org/obo/NCIT_C38784) (Apoptosis Pathway))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38770](http://purl.obolibrary.org/obo/NCIT_C38770) (Squamous Differentiation))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38762](http://purl.obolibrary.org/obo/NCIT_C38762) (Thyroid Gland Mucoepidermoid Carcinoma))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3876](http://purl.obolibrary.org/obo/NCIT_C3876) (Gastric Leiomyoma))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38759](http://purl.obolibrary.org/obo/NCIT_C38759) (EBV Infection))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38732](http://purl.obolibrary.org/obo/NCIT_C38732) (Defective Alpha Heavy Chain Present))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38731](http://purl.obolibrary.org/obo/NCIT_C38731) (Villous Atrophy))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38730](http://purl.obolibrary.org/obo/NCIT_C38730) (Lymphoepithelial Lesion))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38727](http://purl.obolibrary.org/obo/NCIT_C38727) (Villous Lymphocyte))) 38.93%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38721](http://purl.obolibrary.org/obo/NCIT_C38721) (Nuclear Pleomorphism))) 38.93%


